New Jersey

Taiho Oncology and Servier Present LONSURF® (trifluridine and tipiracil) Metastatic Colorectal Cancer (mCRC) Data at ASCO 2018 Gastrointestinal Cancers Symposium

PRINCETON, , Jan. 20, 2018 /PRNewswire/ -- Taiho Oncology, Inc. and Servier today announced clinical data for LONSURF® (trifluridine and tipiracil) for the treatment of patients with metastatic colorectal cancer…
Continue Reading »
New Jersey

SHAREHOLDER ALERT – Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Xunlei Limited (XNET) and Lead Plaintiff Deadline: March 20, 2018

NEW YORK, Jan. 19, 2018 /PRNewswire/ -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Xunlei Limited ("Xunlei" or the "Company") (NASDAQ:…
Continue Reading »
New Jersey

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aerohive Networks, Inc. (HIVE)

NEW YORK, Jan. 19, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aerohive Networks, Inc. ("Aerohive " or the…
Continue Reading »
New Jersey

Quest Diagnostics Named One of 2018 “World’s Most Admired Companies” by Fortune Magazine for Third Consecutive Year

SECAUCUS, , Jan. 19, 2018 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most…
Continue Reading »